Dr. Nataniel H. Lester-Coll
Claim this profileUniversity of Vermont Medical Center
Studies Prostate Cancer
Studies Adenocarcinoma
7 reported clinical trials
37 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Adenocarcinoma
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Nataniel H. Lester-Coll is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
More about Nataniel H. Lester-Coll
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Nataniel H. Lester-Coll has experience with
- Radiation Therapy
- Bicalutamide
- Triptorelin
- Flutamide
- Degarelix
- Histrelin
Breakdown of trials Nataniel H. Lester-Coll has run
Prostate Cancer
Adenocarcinoma
Prostate Adenocarcinoma
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nataniel H. Lester-Coll specialize in?
Nataniel H. Lester-Coll focuses on Prostate Cancer and Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Nataniel H. Lester-Coll currently recruiting for clinical trials?
Yes, Nataniel H. Lester-Coll is currently recruiting for 5 clinical trials in Burlington Vermont. If you're interested in participating, you should apply.
Are there any treatments that Nataniel H. Lester-Coll has studied deeply?
Yes, Nataniel H. Lester-Coll has studied treatments such as Radiation Therapy, Bicalutamide, Triptorelin.
What is the best way to schedule an appointment with Nataniel H. Lester-Coll?
Apply for one of the trials that Nataniel H. Lester-Coll is conducting.
What is the office address of Nataniel H. Lester-Coll?
The office of Nataniel H. Lester-Coll is located at: University of Vermont Medical Center, Burlington, Vermont 05401 United States. This is the address for their practice at the University of Vermont Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.